Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-12-02

Clinical Trial Update: Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular Surgery [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating postoperative hyperbaric oxygen to reduce complications in diabetic patients undergoing vascular surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Karolinska Institutet | Conditions: Diabetes, Peripheral Arterial Disease | Phase 2, Phase 3 | Status: WITHDRAWN